About this trial
To uncover the underlying mechanisms of resistance exercise training benefits on glucose metabolism and insulin sensitivity in muscle.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Sedentary (≤30min of physical activity on ≤1 day/week)
Weight stable for ≥3 months prior to study
Disqualifiers
Active coronary artery disease or heart failure.
Participation in a structured exercise program > 1 day/week.
Abnormal liver function test results (Transaminase >2 times the upper limit of normal)
Abnormal renal function test results (calculated GFR <60 mL/min/1.73m2); If on antihypertensive, thyroid, anti-depressant or lipid lowering medication, lack of stability on the medication for the past 2 months prior to enrollment in the study
Trial design
Single group
Treatments tested in this trial
Resistance Exercise Training
Other interventionParticipants will undergo resistance exercise training 3 days a week for approximately 1 hour each day for 8 weeks.
Treatment groups
Trial outcomes
Primary outcomes
Change in muscle protein synthesis
Rate of insulin-stimulated synthesis of individual proteins
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Mayo Clinic
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: